Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_assertion type Assertion NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_head.
- NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_assertion wasGeneratedBy ECO_0000203 NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_provenance.
- NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_assertion wasDerivedFrom befree-20150227 NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_provenance.
- NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_assertion SIO_000772 19470724 NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_provenance.
- NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_assertion evidence source_evidence_literature NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_provenance.
- NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_assertion description "[Novel PLK, CENPE, and AURKB inhibitors should be assessed for therapeutic utility in poor prognosis cyclin B1-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817637.RAZCM6haWkF8E-Sy4-tQd2EPR5dgFQLCn7n0o2Ks5d1IM130_provenance.